Tag: David Weber

All

Latest

Otonomy Announces Financial Updates

Otonomy, Inc. announced a set of immediate actions to preserve capital, extend its cash runway, and build shareholder value following the recent negative AVERTS-1 Phase 3 trial results for OTIVIDEX in Ménière’s disease.

All

Latest
Sorry, No Posts Found
Sorry, No Posts Found